Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

An arthritis drug helped a person with severe hair loss regrow their hair.

Entospletinib effectively prevents eye and skin GVHD in mice.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.